MedTech News
.................... by Andrew Celentano
Nia Therapeutics wins FDA breakthrough nod for neuromod that treats memory loss
Nia Therapeutics announced today that it received FDA breakthrough device designation for its Smart Neurostimulation System (SNS).
Smartphone tool can monitor tissue health by reading a natural oxygen-sensitive molecule
Dartmouth researchers have developed a cell phone-based tool that monitors tissue health by using a naturally occurring molecule to measure the oxygen level in cells.
Precision radio waves may help counter brain diseases
A study has found that precise application of radio waves can change the activity of brain cells in ways that could counter neurological conditions.
Prototype breath tests spot bacterial infections in minutes
Now, research published in ACS Central Science could help health care professionals non-invasively diagnose bacterial infections, using breath-based tests.
Novel X-ray technique could transform tissue diagnosis
A new X-ray imaging technique could transform how hospitals analyze tissue samples, potentially speeding up diagnoses and improving outcomes for patients, shows a new study led by UCL researchers. The technology, developed in collaboration with the Memorial Sloan Kettering Cancer Center, Rigaku Americas and Creatv MicroTech, Inc., produces crisp 3D maps of biological tissue without cutting or staining samples, a significant improvement on the conventional process used in histopathology—the process of examining tissue to study, diagnose and treat diseases, particularly cancer.
Nasal swab test spots early Alzheimer’s signals
Duke Health researchers show that a quick, outpatient nasal swab can pick up early biological changes linked to Alzheimer’s, even before thinking and memory problems appear.
Scientists create cancer-fighting immune cells right in the body
Now, scientists at UC San Francisco have developed a method to precisely reprogram these cancer-fighting cells directly inside the body, potentially eliminating the manufacturing process, cost, and waiting time that has kept this life-saving therapy out of reach for many patients around the world.
DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical’s Global Expansion
SUZHOU, China, March 18, 2026 /PRNewswire/ — Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its DCwire® Micro Guidewire has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) on March 17, 2026. The product was independently designed and developed by Achieva Medical Limited, a subsidiary of the Company.